Inspired to change the face of childhood stroke, one discovery at a time

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 4/10/2017: 12:00 AM
Ends On: 4/10/2019: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 1
Description:

Faculty


Timothy J. Bernard, MD, MSCS
Director, Pediatric Stroke Program
Associate Professor of Pediatrics, Neurology and Child Neurology
University of Colorado School of Medicine
Director of Clinical Research, Children's Clinical Research Organization
Children's Hospital Colorado Research Institute
Disclosures: Dr. Bernard has no financial relationships to disclose.

This activity originated as a presentation at the CME activity, 7th Annual World Pediatric Stroke Association Lecture (formerly Brendon's Smile Foundation Pediatric Stroke Lecture) on Pediatric Stroke, May 27, 2016.

This activity is being supported with a grant from the World Pediatric Stroke Association.

Planning Committee


Bradley L. Schlaggar, MD, PhD
A. Ernest and Jane G. Stein Professor of Developmental Neurology in Neurology
Professor of Radiology, Anatomy & Neurobiology, & Pediatrics
Director, Pediatric Neurology Residency Training
Disclosures: Dr. Schlaggar has no financial relationships to disclose.

Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • To identify the unique features of childhood stroke presentation
  • To review recent advances in the understanding of childhood stroke, and the capacity for recovery:
    1. Why do some children do so well? Why don't they all?
    2. Time is brain: it's not just about the tPA
    3. Treating the whole child
  • To discuss the factors that may influence functional and quality of life recovery from pediatric stroke in the future


Additional Information:
Target Audience: This course is designed for Internists and Family Medicine physicians, pharmacists, nurse practitioners and physician assistants caring for the Medicare population, though many applications apply to the non-Medicare patient.

Date
Publication Date: April 10, 2017
Expiration Date: April 10, 2019

Accreditation Information:
wustlcme
In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis and World Pediatric Stroke Association. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement: Washington University School of Medicine in St. Louis designates this Enduring material for a maximum of 1 AMA PRA Category 1 Credit ™. Learners should claim only the credit commensurate with the extent of their participation in the activity.

References:
  • Fullerton et al. Neurology. 2002;59:34–39
  • Golomb et al. Stroke, 2009 Jan 1;40(1):e8-10
  • Goldenberg et al. Lancet Neurology, 2009; 8: 1120–1127
  • Yock-Corrales et al. Aust Fam Physician. Jan-Feb;40(1-2):35-8. 2011
  • Srinivasan J et al., 2011 The highly conserved KEOPS/EKC complex is essential for a universal tRNA modification, t6A. EMBO J 30(5):873-81
  • Amlie-Lefond et al. Pediatr Neurol. 2011 Apr;44(4):299-302
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.

Category: World Pediatric Stroke Lectures


Powered By AI 4.5